Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Qun Xiang

Showing results (151-160 of 177) with videos related to

Pageof 18
Sort By:
Med (New York, N.Y.)|February 20, 2026
Becotatug vedotin, MRG003, in previously treated recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm, phase IIa trialFei Han, Xing Lv, Yu-Juan Zhou, et al.
European Journal of Cancer (Oxford, England : 1990)|February 6, 2017
Survival impact of waiting time for radical radiotherapy in nasopharyngeal carcinoma: A large institution-based cohort study from an endemic areaHu Liang, Yan-Qun Xiang, Xing Lv, et al.
Journal of the National Cancer Institute|November 8, 2011
Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trialQiu-Yan Chen, Yue-Feng Wen, Ling Guo, et al.
Oncotarget|April 1, 2015
WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesisLi Qin, Yan-Tao Yin, Fang-Jing Zheng, et al.
JAMA Oncology|October 13, 2022
Adjuvant Capecitabine Following Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Randomized Clinical TrialJingjing Miao, Lin Wang, Sze Huey Tan, et al.
Journal of Cancer|September 14, 2018
Concurrent Chemoradiotherapy versus Intensity-modulated Radiotherapy Alone for Elderly Nasopharyngeal Carcinoma Patients with Pre-treatment Epstein-Barr Virus DNA: A Cohort Study in an Endemic Area with Long-term Follow-upQin Yang, Ting-Ting Zhao, Meng-Yun Qiang, et al.
Plos One|December 17, 2013
Genetic variations in radiation and chemotherapy drug action pathways and survival in locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapyHuai Liu, Bin Qi, Xiang Guo, et al.
Cancer Research|February 4, 2011
Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasisXin-Jian Li, Choon Kiat Ong, Yun Cao, et al.
Medical Oncology (Northwood, London, England)|August 20, 2013
Functional polymorphisms of matrix metalloproteinase-9 and survival in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapyHuai Liu, Pei-Yu Huang, Lin-Quan Tang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|October 6, 2009
Induction-concurrent chemoradiotherapy versus induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinomaPei-Yu Huang, Hai-Qiang Mai, Dong-Hua Luo, et al.
Pageof 18

Showing results (151-160 of 177) with videos related to

Sort By:
Pageof 18
Med (New York, N.Y.)|February 20, 2026
Becotatug vedotin, MRG003, in previously treated recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm, phase IIa trialFei Han, Xing Lv, Yu-Juan Zhou, et al.
European Journal of Cancer (Oxford, England : 1990)|February 6, 2017
Survival impact of waiting time for radical radiotherapy in nasopharyngeal carcinoma: A large institution-based cohort study from an endemic areaHu Liang, Yan-Qun Xiang, Xing Lv, et al.
Journal of the National Cancer Institute|November 8, 2011
Concurrent chemoradiotherapy vs radiotherapy alone in stage II nasopharyngeal carcinoma: phase III randomized trialQiu-Yan Chen, Yue-Feng Wen, Ling Guo, et al.
Oncotarget|April 1, 2015
WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesisLi Qin, Yan-Tao Yin, Fang-Jing Zheng, et al.
JAMA Oncology|October 13, 2022
Adjuvant Capecitabine Following Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Randomized Clinical TrialJingjing Miao, Lin Wang, Sze Huey Tan, et al.
Journal of Cancer|September 14, 2018
Concurrent Chemoradiotherapy versus Intensity-modulated Radiotherapy Alone for Elderly Nasopharyngeal Carcinoma Patients with Pre-treatment Epstein-Barr Virus DNA: A Cohort Study in an Endemic Area with Long-term Follow-upQin Yang, Ting-Ting Zhao, Meng-Yun Qiang, et al.
Plos One|December 17, 2013
Genetic variations in radiation and chemotherapy drug action pathways and survival in locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapyHuai Liu, Bin Qi, Xiang Guo, et al.
Cancer Research|February 4, 2011
Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasisXin-Jian Li, Choon Kiat Ong, Yun Cao, et al.
Medical Oncology (Northwood, London, England)|August 20, 2013
Functional polymorphisms of matrix metalloproteinase-9 and survival in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapyHuai Liu, Pei-Yu Huang, Lin-Quan Tang, et al.
AI Zheng = Aizheng = Chinese Journal of Cancer|October 6, 2009
Induction-concurrent chemoradiotherapy versus induction chemotherapy and radiotherapy for locoregionally advanced nasopharyngeal carcinomaPei-Yu Huang, Hai-Qiang Mai, Dong-Hua Luo, et al.
Pageof 18